Finland – Research and development services and related consultancy services – Nanomaterial Risk Assessment: Refining and Validating Acceptable Variation in Nanoform Characterisers

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Reinforcing EU strategic autonomy by reducing non-EU dependencies on critical space EEE components and related technologies across their entire supply chain; Providing unrestricted access to critical space EEE components and related technologies relevant for EU space missions (Galileo, EGNOS, Copernicus, IRIS 2 and EU pilot missions on In-Orbit Space Operations and Quantum Gravimetry); Developing or regaining capacity to operate independently in space by developing resilient space EEE components and related technologies supply chains, relying on EU supply chains and/or trustable and reliable supply chains not affected by non-EU export restrictions; Enhancing competitiveness by developing products and capabilities reaching equivalent or superior performance level than those from outside the EU and compete at worldwide level. Scope: Unrestricted access to state-of-art space EEE components and related technologies is a pre-requisite for the EU space industry responding to EU space missions. However, especially for some families of components, the available solutions in EU do not…

Expected Outcome: the project results are expected to contribute to all of the following outcomes: access to cutting-edge infrastructure for researchers and research teams from Euratom and Associated Countries to EU and international state-of-the-art nuclear research infrastructures; enhancing the network developed under the OFFERR project for optimised use of nuclear research infrastructures identified in the EU, thus supporting the implementation of the Euratom programme’s objectives and the establishment of the European Research Area (ERA) in the nuclear safety and radiation protection field; strengthened cross-border collaboration in nuclear safety and radiation protection research in the EU, a significant increase in transnational nuclear research and the fostering of shared expertise and resources; preservation of critical facilities, possibly increasing their number to ensure the long-term availability of key experimental facilities for research into safety, security, safeguards, radioactive waste management and radiation protection (e.g. materials testing research reactors in operation, irradiation infrastructure, hot cells and laboratories, mechanical and thermal…

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: impacts of continuous and impulsive underwater noise levels on marine organisms and ecosystems, and the related ecosystem services they provide, including cumulative impacts with other pressures, are well understood, taking into account regional differences; environmental authorities have access to advanced methods, tools and indicators enabling them to comprehensively monitor and assess the impacts of underwater noise pollution on marine species and ecosystems and to devise strategies for protecting the ecosystems services they provide. Scope: Proposals should: develop new, or improve upon existing, scientific methods and tools for comprehensively monitoring the impacts of anthropogenic underwater noise pollution on marine ecosystems and species populations at different trophic levels and taking into account regional differences; develop new, or improve upon existing, indicators for the assessment of the effects of noise exposure as well as their cumulative effects on marine organisms and ecosystems, and the services they provide, in line with methods (including threshold…

Expected Outcome: Objectives and profile of the ERC Plus Grant Principal Investigator The ERC Plus Grant supports outstanding Principal Investigators who address a major scientific challenge. Applications for ERC Plus Grants should be for projects that could not be carried out with a regular ERC grant. Applicants should explain how the proposed project aims go beyond those of a regular ERC project, for example, because they have a vision to transform their field or open a new field of research. Scholars at all career stages can apply for an ERC Plus Grant if they have an outstanding record of scientific achievement at the forefront of their field. Their intellectual leadership will be evaluated in comparison to peers at their own career stage. It is expected that a researcher may be the Principal Investigator of only one ERC Plus Grant in their lifetime. Applicants should be aware that every year, only some 30 ERC Plus Grants can be awarded across all fields and all career stages, compared to approximately 1000 Starting, Consolidator and Advanced Grants. This level of competitiveness should be taken into account when considering whether to submit an application. Size of ERC Plus…

Expected Outcome: Proposals are expected to contribute to all following points: Significantly reduced EU dependency on imported battery-grade raw materials, specifically emerging technologies and carbon-based electrode materials. Established European value chains for next-generation battery materials, enhancing the EU's technological leadership and strategic autonomy. Scope: Proposals under this topic are expected to address all aspects for one of the following categories: 1. Sustainable Processing and Refining of next generation batteries-grade Material, delivering all of the following: Development and validation of innovative, environmentally friendly refining technologies for producing battery-grade metals and materials suitable for next-generation battery chemistries. This covers raw and advanced electrode materials for the components of sodium-ion batteries or beyond generation 3 [1] lithium-ion batteries Development of processes achieving significant reductions in carbon and ecological footprint, emissions of pollutants, energy usage, and chemical inputs. The selected processes should not negatively impact any of the aspects above or cause significant harm. Validation of…

Expected Outcome: Proposals are expected to contribute to all the following expected outcomes: Accelerate the use of innovative technologies to decarbonise industrial processes and bring to the market more cost-effective clean products to strengthen the competitiveness, sustainability (including biodiversity), and resilience of EU industries; Create new innovative first-of-a-kind operational demonstrators and/or optimise newly installed industrial decarbonisation solutions in Europe; and Demonstrate the market readiness of the envisaged future clean products and their innovative processes via a credible business plan and an exploitation strategy for industrialisation, including market-tested use cases. Scope: The Clean Industrial Deal aims to secure the EU as an attractive location for manufacturing, including for energy-intensive industries, and to promote clean tech and new circular business models in order to meet Europe’s ambitious decarbonisation and climate neutrality targets. It focuses primarily on the competitive decarbonisation of EU industry and on the production of clean technologies in the EU. The following three technology areas on energy intensive industries having…

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that employ mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally

Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots. There are two funding opportunities per year that are open to all targets.